TY - JOUR AU - JB Perz, AU - JS Khorashad, AU - D Marin, AU - JF Apperley, AU - E Olavarria, PY - 2006/08/01 Y2 - 2024/03/28 TI - Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia JF - Haematologica JA - haematol VL - 91 IS - 8 SE - Letters to the Editor DO - 10.3324/%x UR - https://haematologica.org/article/view/4111 SP - 1145-1146 AB - In 37 adults with chronic myeloid leukemia undergoing allogeneic stem cell transplantation imatinib prior to transplant had no discernible negative impact on 100-day mortality (13%) and severe acute (22%) or extensive chronic graft-versus- host disease (31%). After a median of 203 days (range: 18-1419) overall and progression-free survival rates are 62% and 54%, respectively. ER -